[Crohn disease and bronchiolitis obliterans organizing pneumonia].

S. Asensio Sánchez,P. Alba García-Baquero,V. Villena

Archivos de Bronconeumologia

Abstract:

What problem does this paper attempt to address?

Depression, anxiety, and stress in pregnancy and postpartum: A longitudinal study during the COVID-19 pandemic

Emily P Rabinowitz,Lindsay A Kutash,Alexis L Richeson,MacKenzie A Sayer,Marielle R Samii,Douglas L Delahanty

DOI: https://doi.org/10.1016/j.midw.2023.103655

IF: 2.64

Midwifery

Abstract:Introduction: Symptoms of depression, anxiety, and stress in pregnant women are generally highest in the first trimester and then decrease throughout pregnancy, reaching their lowest point in the postpartum period. Pregnant women are a high-risk population for mortality and mental health symptoms due to COVID-19. However, the extent to which the chronic stress of the COVID-19 pandemic alters the trajectory of depression, anxiety and stress symptoms in pregnant/postpartum women is unknown. Methods: Women (N=127) who were pregnant or who had given birth less than one month prior were recruited via online advertising during the COVID-19 pandemic. Participants were assessed up to three times during the pregnancy and at 1-month postpartum for depression (Edinburgh Postnatal Depression Scale), anxiety, and stress (Depression, Anxiety, and Stress Scale-21). Random intercepts models examined symptom change over time as well as predictors of elevated postpartum psychopathology. Results: On average, women completed their surveys at 8.5 weeks (first trimester), 21 weeks (second trimester), 32 weeks (third trimester) and 7-weeks postpartum. Women reported mild-moderate levels of depression, anxiety, and stress throughout pregnancy. There was a significant change in symptoms of depression and anxiety over time which was best represented by a quadratic rather than linear trajectory: symptoms increased until week 23-25 and then decreased. Stress levels remained consistently elevated over time. Higher symptom levels at 1-month postpartum were predicted by younger age, lower social support, and worry about going to a healthcare facility. Change in routine due to COVID-19 was not predictive of symptom trajectory from pregnancy to postpartum. Conclusions: During COVID-19, symptoms of depression and anxiety increased from early to mid-pregnancy but then declined slightly while stress levels remained elevated. Observed reductions in symptoms were small. Given the substantial persistent impact of perinatal distress and poor mental health on maternal and fetal health, providers should be aware of heightened levels of these symptoms in pregnant women during large-scale external health stressors such as COVID-19, and should implement screening procedures to identify and appropriately intervene with at-risk women.
Depression, anxiety, and stress symptoms in pregnant women before and during the COVID-19 pandemic

Hong Mei,Na Li,Junwei Li,Dan Zhang,Zhongqiang Cao,Yongjie Zhou,Jiangxia Cao,Ai'fen Zhou

DOI: https://doi.org/10.1016/j.jpsychores.2021.110586

IF: 4.62

2021-10-01

Journal of Psychosomatic Research

Abstract:ObjectiveThis study evaluates depression, anxiety, and stress symptoms in pregnant women before and during COVID-19 pandemic and analyzes their risk factors.MethodsThis was a cross-sectional analyses included pregnant women with depression, anxiety, and stress levels evaluated both in the Novel Coronavirus-Pregnancy Cohort study (NCP) and the Healthy Baby Cohort study (HBC). NCP was conducted during COVID-19 pandemic, while HBC was performed before the pandemic. Multiple logistic regressions were employed to evaluate the associations between COVID-19 pandemic and other co-variables and maternal mental health.ResultsNCP and HBC studies respectively included 531 and 2352 participants. Depression rates differed significantly between the two studies (p < 0.05). The mild and moderate-to-severe depression rates in NCP study were 25.8% and 10.36%, respectively, and 19.94% and 0.55% in HBC study. The stress rate of participants was higher in HBC study (69.39%) than in NCP study (60.45%) (p < 0.05). COVID-19 pandemic was correlated with higher depression but lower stress risks (p < 0.05) in pregnant women, with OR and 95% CI as 1.68 (1.16, 2.44) and 0.42 (0.29, 0.61), respectively. Pregnant women with pre-pregnancy obesity and high educational levels might have lower risks for depression, anxiety, and stress than those with normal weight and low educational levels.ConclusionsDepression among pregnant women was impacted by the pandemic. Apart from COVID-19 pandemic impact, pre-pregnant weight status and educational level might also influence depression, anxiety and stress statuses in pregnant women.

psychiatry
Investigating Factors Influencing Prenatal Stress, Anxiety, and Fear of Childbirth During the COVID-19 Pandemic in Germany and Switzerland: An Online Survey

Rita T Amiel Castro,Nora K Schaal,Hannah Meyerhoff,Heidi Preis,Brittain Mahaffey,Marci Lobel,Pearl La Marca-Ghaemmaghami

DOI: https://doi.org/10.1007/s10995-023-03758-6

Abstract:Objectives: Pregnant women are likely to experience high levels of stress during the COVID-19 pandemic. However, the factors that might influence the extent of experienced emotional distress are poorly understood. Therefore, we aimed to investigate potential correlates of prenatal emotional distress during the COVID-19 pandemic. Methods: In total, N = 1437 pregnant women from Germany and Switzerland participated in an online study during the first wave of the COVID-19 pandemic (May-August 2020). The survey assessed prenatal distress, pandemic-related pregnancy stress, general anxiety, fear of childbirth, and several socio-demographic, pregnancy- and COVID-19-related factors. Linear multivariate regression models were the main analytical strategy. Results: The results highlight that several factors such as full-time employment, nulliparity, high-risk pregnancy, emotional problems, cancelled prenatal appointments, and stating that COVID-19 affected the choice of birth mode were significantly associated with elevated prenatal distress, anxiety, pandemic-related pregnancy stress, and fear of childbirth. Conversely, access to an outdoor space was a protective factor for pandemic-related pregnancy stress and prenatal distress. Conclusions for practice: Overall, the study highlights significant correlates influencing the levels of emotional distress pregnant women experienced during the COVID-19 pandemic. These findings may contribute to the improvement of maternal prenatal medical and psychological care during a public health crisis of international concern, such as the COVID-19 pandemic.
Women's Depressive Symptoms during the COVID-19 Pandemic: The Role of Pregnancy

Karen Yirmiya,Noa Yakirevich-Amir,Heidi Preis,Amit Lotan,Shir Atzil,Inbal Reuveni

DOI: https://doi.org/10.3390/ijerph18084298

2021-04-18

Abstract:The Coronavirus Disease 2019 (COVID-19) pandemic has multiple ramifications for pregnant women. Untreated depression during pregnancy may have long-term effects on the mother and offspring. Therefore, delineating the effects of pregnancy on the mental health of reproductive-age women is crucial. This study aims to determine the risk for depressive symptoms in pregnant and non-pregnant women during COVID-19, and to identify its bio-psycho-social contributors. A total of 1114 pregnant and 256 non-pregnant women were recruited via social media in May 2020 to complete an online survey that included depression and anxiety questionnaires, as well as demographic, obstetric and COVID-19-related questionnaires. Pregnant women also completed the Pandemic-Related Pregnancy Stress Scale (PREPS). Pregnant women reported fewer depressive symptoms and were less concerned that they had COVID-19 than non-pregnant women. Among pregnant women, risk factors for depression included lower income, fewer children, unemployment, thinking that one has COVID-19, high-risk pregnancy, earlier gestational age, and increased pregnancy-related stress. Protective factors included increased partner support, healthy behaviors, and positive appraisal of the pregnancy. Thus, being pregnant is associated with reduced risk for depressive symptoms during the pandemic. Increased social support, engaging in health behaviors and positive appraisal may enhance resilience. Future studies of pregnant versus non-pregnant women could clarify the role of pregnancy during stressful events, and clarify aspects of susceptibility and resilience during pregnancy.
Associations of stress, anxiety, and partner satisfaction with maternal-fetal attachment in women pregnant during the COVID-19 pandemic: an online study

Nora K Schaal,Pearl La Marca-Ghaemmaghami,Sarah Märthesheimer,Philip Hepp,Heidi Preis,Brittain Mahaffey,Marci Lobel,Rita Amiel Castro

DOI: https://doi.org/10.1186/s12884-023-05804-1

2023-06-30

Abstract:Background: The COVID-19 pandemic has led to exceptional stress in pregnant women. The aim of the present study was to investigate associations of maternal stress (pandemic-related and -unrelated), anxiety, and relationship satisfaction experienced during the COVID-19 pandemic with prenatal mother-infant attachment. Methods: An online study was conducted evaluating pandemic-related stress, pregnancy-specific stress (unrelated to the pandemic), anxiety, partnership satisfaction, and maternal-fetal attachment in German-speaking women during the second COVID-19 lockdown between January and March 2021. In total, 431 pregnant women (349 lived in Germany and 82 in Switzerland) filled in the questionnaires and gave information on demographic and pregnancy-related variables (i.e. age, gestational age, parity). Bivariate correlations were calculated in order to investigate associations between the different variables and additionally, a hierarchical regression model was conducted in order to evaluate the influence of the independent variables on prenatal attachment. Results: The hierarchical regression analysis revealed that after controlling for age, gestational age, and parity higher pandemic-related stress, namely stress associated with feeling unprepared for birth, higher partnership satisfaction as well as higher positive appraisal (considered as a way of coping with pandemic-related stress) was associated with stronger maternal-fetal attachment, whereas associations of anxiety and other forms of stress were non-significant. Conclusions: The study highlights interesting associations between maternal pandemic-related preparedness stress and positive appraisal of the pregnancy as well as partnership satisfaction and prenatal attachment in women pregnant during the COVID-19 pandemic.
Increased risks of Maternal Mental Health Conditions Following the COVID-19 Pandemic

Anita Zhou,Allison Zetterman,Megan Ott,Colman Freel,Kayla Adams,Andrea Rodriguez-Dasta,Rebekah Rapoza,Rebecca Drakowski,Sarah Sweeney,Alyssa Freeman,Matthew VanOrmer,Melissa Thoene,Elizabeth Lyden,Charmayne R Adams,Gurudutt Pendyala,Corrine Hanson,Ashley J Blount,Ann Anderson-Berry

DOI: https://doi.org/10.1089/whr.2024.0070

2024-10-21

Abstract:Background: Women are at an increased risk of developing psychiatric conditions such as anxiety and depression during pregnancy. Psychiatric conditions during pregnancy can put mothers and fetuses at risk of worse physical and mental health before, during, and after the completion of a pregnancy. Previous research indicates that women pregnant during COVID-19 were at a greater risk of developing mental health conditions and being exposed to stressors. While most of the research in the field focuses solely on maternal mental health or interactions between stressors and maternal mental health, little research has been done comparing maternal mental health, demographic variables, and socioeconomic variables across pre-, during-, and post-COVID-19 time periods. Methods: We conducted an observational cohort study of 703 mothers divided into pre-, during-, and post-COVID-19 groups based on time of enrollment. Results: Rates of maternal anxiety (p < 0.001), medication use for anxiety (p < 0.001), depression (p < 0.001), medication use for depression (p < 0.001), history of postpartum depression (p < 0.001), and medication use for other psychiatric conditions (p < 0.001) significantly increased during COVID-19 and remained at elevated levels post-COVID-19 compared with pre-COVID-19. Income >150% of the poverty level (p = 0.003), food security level (p = 0.010), marital status (p = 0.001), and private insurance type (p < 0.001) were significantly increased during COVID-19 compared with pre-COVID-19 levels. Conclusions: Future work should focus on stratifying the effects of the COVID-19 pandemic on maternal mental health by race and ethnicity and establishing guidelines to support maternal mental health during epidemics and pandemics.
Mental health status of pregnant and breastfeeding women during the COVID‐19 pandemic—A multinational cross‐sectional study

Michael Ceulemans,Veerle Foulon,Elin Ngo,Alice Panchaud,Ursula Winterfeld,Léo Pomar,Valentine Lambelet,Brian Cleary,Fergal O'Shaughnessy,Anneke Passier,Jonathan L. Richardson,Titia Hompes,Hedvig Nordeng

DOI: https://doi.org/10.1111/aogs.14092

2021-02-13

Acta Obstetricia Et Gynecologica Scandinavica

Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Introduction</h3><p>Evidence on perinatal mental health during the COVID‐19 pandemic and its potential determinants is limited. Therefore, this multinational study aimed to assess the mental health status of pregnant and breastfeeding women during the pandemic, and to explore potential associations between depressive symptoms, anxiety and stress, and women's socio‐demographic, health and reproductive characteristics.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Material and methods</h3><p>A cross‐sectional, web‐based study was performed in Ireland, Norway, Switzerland, the Netherlands, and the UK between 16 June and 14 July 2020. Pregnant and breastfeeding women up to three months postpartum who were older than 18 years were eligible. The online, anonymous survey was promoted via social media and hospital websites. The Edinburgh Depression Scale (EDS), the Generalized Anxiety Disorder 7‐item scale (GAD‐7), and the Perceived Stress Scale (PSS) were used to assess mental health status. Regression model analysis was used to identify factors associated with poor mental health status.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>In total, 9041 women participated (including 3907 pregnant and 5134 breastfeeding women). The prevalence of major depressive symptoms (Edinburgh Depression Scale ≥13) was 15% and 13% in the pregnancy and breastfeeding cohort, respectively. Moderate to severe generalized anxiety symptoms (GAD≥10) were found among 11% and 10% of the pregnant and breastfeeding women. The mean(±SD) Perceived Stress Scale scores for pregnant and breastfeeding women were 14.1±6.6 and 13.7±6.6, respectively. Risk factors associated with poor mental health included having a chronic mental illness, a chronic somatic illness in the postpartum period, smoking, having an unplanned pregnancy, professional status, and living in the UK or Ireland.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>This multinational study found high levels of depressive symptoms and generalized anxiety among pregnant and breastfeeding women during the COVID‐19 outbreak. The study findings underline the importance of monitoring perinatal mental health during pandemics and other societal crises to safeguard maternal and infant mental health.</p></section>

obstetrics & gynecology
The mental health crisis of expectant women in the UK: effects of the COVID-19 pandemic on prenatal mental health, antenatal attachment and social support

Maria Laura Filippetti,Alasdair D. F. Clarke,Silvia Rigato

DOI: https://doi.org/10.1186/s12884-022-04387-7

2022-01-26

BMC Pregnancy and Childbirth

Abstract:Abstract Background Pregnancy has been shown to be times in a woman’s life particularly prone to mental health issues, however a substantial percentage of mothers report subclinical perinatal mental health symptoms that go undetected. Experiences of prenatal trauma, such as the COVID-19 pandemic, may exacerbate vulnerability to negative health outcomes for pregnant women and their infants. We aimed to examine the role of: 1) anxiety, depression, and stress related to COVID-19 in predicting the quality of antenatal attachment; 2) perceived social support and COVID-19 appraisal in predicting maternal anxiety and depression. Methods A sample of 150 UK expectant women were surveyed during the COVID-19 pandemic. Questions included demographics, pregnancy details, and COVID-19 appraisal. Validated measures were used to collect self-reported maternal antenatal attachment (MAAS), symptoms of anxiety (STAI), depression (BDI-II), and stress related to the psychological impact of COVID-19 (IES-r). Results We found that the pandemic has affected UK expectant mothers’ mental health by increasing prevalence of depression (47%), anxiety (60%) and stress related to the psychological impact of COVID-19 (40%). Women for whom COVID-19 had a higher psychological impact were more likely to suffer from depressive (95% HDPI = [0.04, 0.39]) and anxiety symptoms (95% HPDI = [0.40, 0.69]). High depressive symptoms were associated with reduced attachment to the unborn baby (95% HPDI [-0.46, -0.1]). Whilst women who appraised the impact of COVID-19 to be more negative showed higher levels of anxiety (HPDI = [0.15, 0.46]), higher social support acted as a protective factor and was associated with lower anxiety (95% HPDI = [-0.52, -0.21]). Conclusions The current findings demonstrate that direct experience of prenatal trauma, such as the one experienced during the COVID-19 pandemic, significantly amplifies mothers’ vulnerability to mental health symptoms and impairs the formation of a positive relationship with their unborn baby. Health services should prioritise interventions strategies aimed at fostering support for pregnant women.

obstetrics & gynecology
Elevated depression and anxiety symptoms among pregnant individuals during the COVID-19 pandemic

Catherine Lebel,Anna MacKinnon,Mercedes Bagshawe,Lianne Tomfohr-Madsen,Gerald Giesbrecht

DOI: https://doi.org/10.1016/j.jad.2020.07.126

IF: 6.533

2020-12-01

Journal of Affective Disorders

Abstract:BackgroundAnxiety and depression symptoms in pregnancy typically affect between 10 and 25% of pregnant individuals. Elevated symptoms of depression and anxiety are associated with increased risk of preterm birth, postpartum depression, and behavioural difficulties in children. The current COVID-19 pandemic is a unique stressor with potentially wide-ranging consequences for pregnancy and beyond.MethodsWe assessed symptoms of anxiety and depression among pregnant individuals during the current COVID-19 pandemic and determined factors that were associated with psychological distress. 1987 pregnant participants in Canada were surveyed in April 2020. The assessment included questions about COVID-19-related stress and standardized measures of depression, anxiety, pregnancy-related anxiety, and social support.ResultsWe found substantially elevated anxiety and depression symptoms compared to similar pre-pandemic pregnancy cohorts, with 37% reporting clinically relevant symptoms of depression and 57% reporting clinically relevant symptoms of anxiety. Higher symptoms of depression and anxiety were associated with more concern about threats of COVID-19 to the life of the mother and baby, as well as concerns about not getting the necessary prenatal care, relationship strain, and social isolation due to the COVID-19 pandemic. Higher levels of perceived social support and support effectiveness, as well as more physical activity, were associated with lower psychological symptoms.ConclusionThis study shows concerningly elevated symptoms of anxiety and depression among pregnant individuals during the COVID-19 pandemic, that may have long-term impacts on their children. Potential protective factors include increased social support and exercise, as these were associated with lower symptoms and thus may help mitigate long-term negative outcomes.

psychiatry,clinical neurology
The risk and protective factors of heightened prenatal anxiety and depression during the COVID-19 lockdown

Stefania Vacaru,Roseriet Beijers,Pamela D. Browne,Mariëlle Cloin,Hedwig van Bakel,Marion I. van den Heuvel,Carolina de Weerth

DOI: https://doi.org/10.1038/s41598-021-99662-6

IF: 4.6

2021-10-12

Scientific Reports

Abstract:Abstract While pregnant women are already at-risk for developing symptoms of anxiety and depression, this is heightened during the COVID-19 pandemic. We compared anxiety and depression symptoms, as indicators of psychological distress, before and during COVID-19, and investigated the role of partner, social network and healthcare support on COVID-19-related worries and consequently on psychological distress. A national survey, conducted during the first lockdown in The Netherlands, assessed COVID-19 experiences and psychological distress (N = 1421), whereas a comparison sample (N = 1439) was screened for psychological distress in 2017–2018. During COVID-19, the percentage of mothers scoring above the questionnaires’ clinical cut-offs doubled for depression (6% and 12%) and anxiety (24% and 52%). Women reported increased partner support during COVID-19, compared to pre-pandemic, but decreased social and healthcare support. Higher support resulted in lower COVID-19-related worries, which in turn contributed to less psychological distress. Results suggest that a global pandemic exerts a heavy toll on pregnant women’s mental health. Psychological distress was substantially higher during the pandemic than the pre-pandemic years. We identified a protective role of partner, social, and healthcare support, with important implications for the current and future crisis management. Whether increased psychological distress is transient or persistent, and whether and how it affects the future generation remains to be determined.

multidisciplinary sciences
Pandemic-related prenatal maternal stress, model of maternity care and postpartum mental health: The Australian BITTOC study

Belinda Lequertier,Mia A McLean,Sue Kildea,Suzanne King,Hazel Keedle,Jacqueline A Boyle,Hannah G Dahlen

DOI: https://doi.org/10.1016/j.wombi.2024.101827

2024-09-28

Abstract:Problem: Women pregnant during the COVID-19 pandemic may be at risk of elevated postpartum mental health problems. Background: Social support protects maternal mental health during a pandemic. It is possible that formal supports, such as continuity maternity models of care, may also support maternal wellbeing. Aim: To investigate whether model of care moderates the association between prenatal maternal stress from the COVID-19 pandemic, and postpartum (a) depression and (b) anxiety. Methods: Women in Australia, pregnant during the COVID-19 pandemic (n = 3048), completed a survey detailing their COVID-19-related objective hardship and subjective distress during pregnancy and completed depression and anxiety measures at birth to six weeks ("Early"), seven to 21 weeks ("Moderate"), and/or 22-30 weeks ("Late") postpartum. Findings: Higher subjective distress was associated with elevated depression and anxiety at all timepoints. Model of care did not moderate the association of objective hardship or subjective distress and depression or anxiety at any timepoint. Compared with Standard Care, women receiving private midwifery care had a 74 % reduction in the odds of elevated anxiety in early postpartum. Discussion: Women receiving private midwifery may have experienced lower anxiety due to a greater duration of postpartum in-home care, fewer changes to service delivery, and the option of homebirth. Women pregnant during a pandemic should be screened for higher subjective distress about the event. Conclusion: These results suggest that continuity of private midwifery care may be beneficial for supporting postpartum mental health during a pandemic, with implications for practice and policy for the current and future pandemics.
The COVID-19 outbreak increases maternal stress during pregnancy, but not the risk for postpartum depression

Myrthe G. B. M. Boekhorst,Lotte Muskens,Lianne P. Hulsbosch,Katrijn Van Deun,Veerle Bergink,Victor J. M. Pop,Marion I. van den Heuvel

DOI: https://doi.org/10.1007/s00737-021-01104-9

2021-04-08

Abstract:Abstract The COVID-19 pandemic affects society and may especially have an impact on mental health of vulnerable groups, such as perinatal women. This prospective cohort study of 669 participating women in the Netherlands compared perinatal symptoms of depression and stress during and before the pandemic. After a pilot in 2018, recruitment started on 7 January 2019. Up until 1 March 2020 (before the pandemic), 401 women completed questionnaires during pregnancy, of whom 250 also completed postpartum assessment. During the pandemic, 268 women filled out at least one questionnaire during pregnancy and 59 postpartum (1 March–14 May 2020). Pregnancy-specific stress increased significantly in women during the pandemic. We found no increase in depressive symptoms during pregnancy nor an increase in incidence of high levels of postpartum depressive symptoms during the pandemic. Clinicians should be aware of the potential for increased stress in pregnant women during the pandemic.
Uptrend in distress and psychiatric symptomatology in pregnant women during the coronavirus disease 2019 pandemic

Nicolas Berthelot,Roxanne Lemieux,Julia Garon‐Bissonnette,Christine Drouin‐Maziade,Élodie Martel,Michel Maziade

DOI: https://doi.org/10.1111/aogs.13925

2020-06-03

Acta Obstetricia Et Gynecologica Scandinavica

Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Introduction</h3><p>Prenatal maternal distress has a negative impact on the course of pregnancy, fetal development, offspring development and later psychopathologies. The study aimed to determine the extent to which the Coronavirus disease 2019 (COVID‐19) pandemic may aggravate pregnant women prenatal distress and psychiatric symptomatology.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Material and methods</h3><p>Two cohorts of pregnant volunteer women were evaluated, one that was recruited before the COVID‐19 pandemic (n=496) through advertisements in prenatal clinics in Quebec, Canada, from April 2018 to March 2020; the other (n=1258) was recruited online during the pandemic from April 2 to April 13 2020. Prenatal distress and psychiatric symptomatology were measured with the Kessler Distress Scale (K10), Post‐traumatic Checklist for DSM‐5 (PCL‐5), Dissociative Experiences Scale (DES‐II) and Positive and Negative Affect Schedule (PANAS).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The 1754 pregnant women (M<sub>age</sub>=29.27, SD=4.23) were between 4 and 41 gestational weeks (M=24.80, SD=9.42), were generally educated (91.3% had post‐high school training) and financially well‐resourced (85.3% were above the low‐income cut‐off). A multivariate analysis of covariance controlling for age, gestational age, household income, education and lifetime psychiatric disorders showed a large effect size (ES) in the difference between the two cohorts on psychiatric symptoms (Wilks' λ=0.68, <i>F </i><sub>6,1400</sub>=108.50, <i>p </i> < 0.001, partial η<sup>2</sup>= 0.32). According to post‐hoc analyses of covariance, the COVID‐19 women reported higher levels of depressive and anxiety symptoms (ES=0.57), dissociative symptoms (ES=0.22 and 0.25), symptoms of post‐traumatic stress disorder (ES=0.19), negative affectivity (ES = 0.96) and less positive affectivity (ES=0.95) than the pre‐COVID‐19 cohort. Women from the COVID‐19 cohort were more likely than pre‐COVID‐19 women to present clinically significant levels of depressive and anxiety symptoms [OR=1.94, <i>χ </i>2(1)=10.05, <i>p </i>=.002]. Multiple regression analyses indicated that COVID‐19 pregnant women having a previous psychiatric diagnosis or low income would be more prone to elevated distress and psychiatric symptoms. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Pregnant women assessed during the COVID‐19 pandemic reported more distress and psychiatric symptoms than pregnant women assessed before the pandemic, mainly in the form of depression and anxiety symptoms. Given the harmful consequences of prenatal distress on mothers and offspring, the presently observed upsurge of symptoms in pregnant women calls for special means of clinical surveillance.</p></section>

obstetrics & gynecology
Economic, Psychological, and Emotional Well‐Being of Pregnant Women During the COVID‐19 Pandemic

Kamal M. Eldeirawi,Victoria W. Persky,Cameron Zielke,Ellen Goldstein,Olivia Bimbi,Jennifer Saenz,Zane Mustafa,Tamara A. Jumah,Xavier R. Ramirez,Ali Aldirawi,Laurie Quinn,Rosalba Hernandez

DOI: https://doi.org/10.1111/jmwh.13659

2024-06-25

Abstract:Introduction The intersection between perinatal mental health and the coronavirus disease 2019 (COVID‐19) pandemic remains of significant public health importance. The current study examined the emotional and financial well‐being and predictors of elevated depressive symptoms among pregnant women during the COVID‐19 pandemic. Methods This online survey was conducted with 2118 women ≥18 years old who were pregnant at the time of the survey and living in the United States or Puerto Rico. Depressive symptoms were assessed with the Center for Epidemiologic Studies Depression Scale, with scores ≥10 indicative of elevated depressive symptoms. The final logistic regression model included housing insecurity, financial distress, COVID‐19 diagnosis, exposure to COVID‐19, and demographic covariates. Results More than half the sample (53.8%) had elevated depressive symptoms. In logistic regression analyses, the odds of having elevated depressive symptoms were significantly higher for participants reporting housing insecurity (adjusted odds ratio [aOR], 1.56; 95% CI, 1.22‐2.01), financial distress (aOR, 1.57; 95% CI, 1.17‐2.12), COVID‐19 diagnosis (aOR, 2.53; 95% CI, 1.53‐4.17), and COVID‐19 exposure (aOR, 1.41; 95% CI, 1.07‐1.86), after adjusting for covariates. The association of elevated depressive symptoms with housing insecurity was especially strong among those who experienced COVID‐19 (aOR, 6.04; 95% CI, 2.15‐17.0). Discussion Our findings are consistent with previous literature revealing that diagnosis, exposure, concerns about family, and effects on financial stability were related to depressive symptoms during the pandemic. The relationships between financial and housing concerns with elevated depressive symptoms, independent of concerns about infection in family members, suggest that there may be direct and indirect effects of the pandemic on mental health.

nursing
Isolation and amino acid sequence of the 9.5 kDa protein of beef heart ubiquinol:cytochrome c reductase

U. Borchart,W. Machleidt,H. Schägger,T. Link,G. von Jagow

DOI: https://doi.org/10.1016/0014-5793(86)80515-4

1986-05-05

FEBS Letters

Abstract:
Docetaxel Induced Durable Response in Advanced Extramammary Paget's Disease: A Case Report

Shinji Oguchi,M. Kaneko,H. Uhara,T. Saida

DOI: https://doi.org/10.1111/j.1346-8138.2002.tb00162.x

2002-01-01

Abstract:The patient was a 54‐year‐old Japanese man with a seven‐month history of an eroded lesion on the scrotum. Skin biopsy confirmed the diagnosis of extramammary Paget's disease, and a CT scan revealed multiple metastases to the lymph nodes along the iliac artery and aorta. The patient underwent combination chemotherapy with mitomycin C, epirubicin, vincristine, cisplatin, and 5‐fluorouracil. After two courses of the regimen, the primary lesions on the scrotum regressed, however, the lymph node metastases did not respond. A regimen of continuous administration of low‐dose cisplatin and 5‐fluorouracil was not effective for the metastases either. Hence, administration of docetaxel at a dose of 60 mg/m2/every four weeks was started. After two courses, the lymph node metastases decreased by 75% compared to the pre‐treatment size, and the effect was judged a partial response. The major toxicities were neutropenia, alopecia, pitting edema, and facial erythema, but these were tolerable. Five courses of this regimen were followed by four courses of weekly administration of 25 mg/m2 docetaxel. The partial response persisted for more than 12 months and the patient was able to enjoy daily life. Docetaxel may be an effective drug for patients with advanced extramammary Paget's disease.
Prenatal maternal mental health and resilience in the United Kingdom during the SARS-CoV-2 pandemic: a cross- national comparison

Swarali Datye,Marko Smiljanic,Rohan Shetti,Alison MacRae-Miller,Edwin van Teijlingen,Latha Vinayakarao,Eva M. J. Peters,Catherine Lebel,Lianne Tomfohr-Madsen,Gerald Giesbrecht,Minesh Khashu,Melanie L. Conrad

DOI: https://doi.org/10.3389/fpsyt.2024.1411761

IF: 4.7

2024-09-26

Frontiers in Psychiatry

Abstract:Introduction Prenatal mental health problems are associated with morbidity for the pregnant person, and their infants are at long-term risk for poor health outcomes. We aim to explore how the SARS-CoV-2 pandemic affected the mental health of pregnant people in the United Kingdom (UK), and to further identify resilience factors which may have contributed to varying mental health outcomes. We also aim to examine the quality of antenatal care provided during the pandemic in the UK and to identify potential inadequacies to enhance preparedness for future events. Methods During June-November 2020, we recruited 3666 individuals in the UK for the EPPOCH pregnancy cohort (Maternal mental health during the COVID-19 pandemic: Effect of the Pandemic on Pregnancy Outcomes and Childhood Health). Participants were assessed for depression, anxiety, anger and pregnancy-related anxiety using validated scales. Additionally, physical activity, social support, individualized support and personal coping ability of the respondents were assessed as potential resilience factors. Results Participants reported high levels of depression (57.05%), anxiety (58.04%) and anger (58.05%). Higher levels of social and individualized support and personal coping ability were associated with lower mental health challenges. Additionally, pregnant individuals in the UK experienced higher depression during the pandemic than that reported in Canada. Finally, qualitative analysis revealed that restrictions for partners and support persons during medical appointments as well as poor public health communication led to increased mental health adversities and hindered ability to make medical decisions. Discussion This study revealed increased mental health challenges among pregnant individuals in the UK during the SARS-CoV-2 pandemic. These results highlight the need for reassessing the mental health support measures available to pregnant people in the UK, both during times of crisis and in general.

psychiatry
Self perceived health and stress in the pregnancy during the COVID-19 pandemic

Cristina Liebana-Presa,María Cristina Martínez-Fernández,Rubén García-Fernández,Cristian Martín-Vázquez,Elena Fernández-Martínez,Pedro Hidalgo-Lopezosa

DOI: https://doi.org/10.3389/fpsyt.2023.1166882

2023-03-31

Abstract:Introduction: The COVID-19 pandemic has had numerous maternal and neonatal consequences, especially at the mental level. Pregnant women experience a rise in anxiety symptoms and prenatal stress. Aims: The aim was to describe self-perceived health status, general stress and prenatal stress and to analyze relations and associations with sociodemographic factors. Methods: A quantitative, descriptive and cross-sectional study was conducted using non-probabilistic circumstantial sampling. The sample was recruited during the first trimester of pregnancy during the control obstetrical visit. The Google Forms platform was used. A total of 297 women participated in the study. The Prenatal Distress Questionnaire (PDQ), the Perceived Stress Score (PSS) and the General Health Questionnaire (GHQ-28) were used. Results: Primiparas presented higher levels of worry about childbirth and the baby (10.93 ± 4.73) than multiparous women (9.88 ± 3.96). Somatic symptoms were present in 6% of the women. Anxiety-insomnia was scored positively by 18% of the women. In the Spearman correlation analysis, statistically significant values were found between almost all study variables. A positive correlation was observed between self-perceived health and prenatal and general stress levels. Discussion: During the first trimester of gestation, prenatal concerns increase when levels of anxiety, insomnia and depression also increase. There is a clear relationship between prenatal worries, anxiety, insomnia and depression with stress. Health education that focuses on mental health of pregnant women would help reduce worries during pregnancy and would improve the pregnant women perception of her health and well-being.
Experiences of Psychological Distress, Symptoms of Anxiety and Depression, and Coping- strategies of Childbearing Women During COVID-19

Miriam S. Johnson,Nora Skjerdingstad,Omid V. Ebrahimi,Asle Hoffart,Sverre Urnes Johnson

DOI: https://doi.org/10.1016/j.midw.2024.103951

IF: 2.64

2024-02-14

Midwifery

Abstract:Background Psychological distress during pregnancy is a well-documented risk factor for adverse maternal outcomes. Distress related to the COVID-19 pandemic may further increase the vulnerability of pregnant women to negative mental health outcomes. Aim To explore the mental health experiences of pregnant focusing on mental health outcomes, challenges related to the pandemic, coping strategies, and factors buffering mental health factors during the restricted COVID-19 lockdown period. Methods A mixed-methods survey study was conducted, examining symptoms of anxiety, depression, and burnout among 21 pregnant women. Qualitative insights were gathered through open-ended questions about participants' current challenges, coping strategies and buffering factors amid the pandemic. Mental health levels were calculated, and qualitative data was thematically analyzed. Results Approximately one-third (24%) of the respondents reported clinically significant levels of depression, 19% reported clinically significant levels of anxiety, and 43% reported experiencing burnout. All participants reported distress and emotional burden, including fear, worry, stress and anxiety related to the ongoing pandemic. Specific concerns such as fear of giving birth alone, fear of the consequences due to lockdown restrictions, insufficient information, disruption of prenatal healthcare services, and fear of miscarriage were prevalent among the participants. Notably, social support, financial stability, stable relationships, adherence to daily routines, reduced stress and social demands, a calmer daily life, physical activity, and less work-related stress including working from home, emerges as buffering factors that aided women in coping with pandemic-related distress. Conclusion Healthcare providers should prioritize stability, predictability, and minimizing disruptions to prenatal care. Broad-based screening is crucial to identify women at risk of depression and anxiety. Recommendations for clinical pathways aimed at pregnant women are discussed.

nursing
Possible Stress-Neuroendocrine System-Psychological Symptoms Relationship in Pregnant Women during the COVID-19 Pandemic

Giulia Gizzi,Claudia Mazzeschi,Elisa Delvecchio,Tommaso Beccari,Elisabetta Albi

DOI: https://doi.org/10.3390/ijerph191811497

2022-09-13

Abstract:The COVID-19 pandemic induced long-term damages that weigh on the national health systems of various countries in terms of support and care. This review aimed to highlight the mental health impact of the COVID-19 pandemic in pregnant women. We first report data on the immune system physiopathology and the main viral infections in pregnancy, including COVID-19. Then, the attention is focused on the main factors that affect the mental health of pregnant women during the COVID-19 pandemic, such as (1) the fear of being infected and transmitting the infection to the fetus, (2) the cancellation of checkups and pre-child courses, and (3) confinement and the inability to have close friends or a partner at the time of delivery or in the first days after delivery, as well as family tensions. Because of all this, pregnant women find themselves in a stressful condition independent of the pregnancy, and thus experience anxiety, depression, insomnia, hostility, delirium, and an alteration of the mother-baby relationship. Several studies have shown an involvement of the hypothalamic-pituitary-adrenal axis and the hypothalamic-pituitary-thyroid axis in response to the pandemic. We propose a possible involvement of the neuroendocrine system as a mediator of the psychological symptoms of pregnant women induced by COVID-19-related stress.

[Crohn disease and bronchiolitis obliterans organizing pneumonia].

Depression, anxiety, and stress in pregnancy and postpartum: A longitudinal study during the COVID-19 pandemic

Depression, anxiety, and stress symptoms in pregnant women before and during the COVID-19 pandemic

Investigating Factors Influencing Prenatal Stress, Anxiety, and Fear of Childbirth During the COVID-19 Pandemic in Germany and Switzerland: An Online Survey

Women's Depressive Symptoms during the COVID-19 Pandemic: The Role of Pregnancy

Associations of stress, anxiety, and partner satisfaction with maternal-fetal attachment in women pregnant during the COVID-19 pandemic: an online study

Increased risks of Maternal Mental Health Conditions Following the COVID-19 Pandemic

Mental health status of pregnant and breastfeeding women during the COVID‐19 pandemic—A multinational cross‐sectional study

The mental health crisis of expectant women in the UK: effects of the COVID-19 pandemic on prenatal mental health, antenatal attachment and social support

Elevated depression and anxiety symptoms among pregnant individuals during the COVID-19 pandemic

The risk and protective factors of heightened prenatal anxiety and depression during the COVID-19 lockdown

Pandemic-related prenatal maternal stress, model of maternity care and postpartum mental health: The Australian BITTOC study

The COVID-19 outbreak increases maternal stress during pregnancy, but not the risk for postpartum depression

Uptrend in distress and psychiatric symptomatology in pregnant women during the coronavirus disease 2019 pandemic

Economic, Psychological, and Emotional Well‐Being of Pregnant Women During the COVID‐19 Pandemic

Isolation and amino acid sequence of the 9.5 kDa protein of beef heart ubiquinol:cytochrome c reductase

Docetaxel Induced Durable Response in Advanced Extramammary Paget's Disease: A Case Report

Prenatal maternal mental health and resilience in the United Kingdom during the SARS-CoV-2 pandemic: a cross- national comparison

Self perceived health and stress in the pregnancy during the COVID-19 pandemic

Experiences of Psychological Distress, Symptoms of Anxiety and Depression, and Coping- strategies of Childbearing Women During COVID-19

Possible Stress-Neuroendocrine System-Psychological Symptoms Relationship in Pregnant Women during the COVID-19 Pandemic